November 18, 2017

Industry Outlook 2006 - Biotech

Moving Forward

Scripps hasn't let site concerns keep it from proceeding with research.

Cynthia Barnett | 1/1/2006

ON TARGET: Scripps Florida has already hired more than 150 scientists and supporting staff as called for in the state-approved incentives package.
With its first choice for a site in rural Palm Beach County bogged in environmental politics, the Scripps Research Institute shifted gears late last year and will try to build its biotech village at the Abacoa campus of Florida Atlantic University in Jupiter.

As the details of a new site deal are hammered out, Scripps is proceeding with a scientific effort that it has mustered largely out of the headlines -- building the backbone of a research effort in Florida that it expects to be a magnet for other research organizations, laboratories and spinoff companies.
Operating from temporary facilities at FAU, Scripps' 160 scientists, technicians and administrative staff are focusing on biomedical research, technology development and drug design. William E. Ray, Scripps vice president for external affairs, says the site issue has been "unremitting, but it is the scientists who make the case for Scripps -- not the site."

Ray says Scripps continues to meet the employment targets spelled out in the $369-million state financing package that helped induce Scripps, headquartered in La Jolla, Calif., to build a research facility in Florida. Meanwhile -- despite courting from other regions of Florida -- Scripps has cemented its commitment to Palm Beach County, where it's received $12 million in private donations. In November, Scripps Florida collaborated with Oxford University to host a major biotech conference in Palm Beach at which scientists from all over the world presented cutting-edge research on topics ranging from Alzheimer's disease to cancer. At the conference, Scripps also announced it was forming a biochemistry department that will encompass the California and Florida campuses; research will span questions in neurobiology, metabolic control, immunology and cancer biology.

Scripps' first promise to Florida was as a baseline for research and development. Its second was the biotechnology village that would lure other companies and venture capital -- finally putting the state on the biotech map. In November, after a federal judge halted construction of major roads and sewers for infrastructure around Scripps' Mecca Farms site near the Everglades due to environmental concerns, the Palm Beach County Commission urged Scripps to find a new place to build.

Until that biotech village is under way, say industry observers inside and outside the state, Florida won't realize the full promise of Scripps. "Scripps, its scientists and the quality of its research are a given. The question is what it will bring to Florida," says Gregory A. Nelson, head of Akerman Senterfitt's intellectual property division in West Palm Beach and a board member of BioFlorida, the state's biotechnology organization. "Scripps is a catalyst, and to the extent that the catalyst isn't there, it prolongs the formation of a biotech cluster in Florida."

Tags: Around Florida

Digital Access

Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

An overview of the features and articles in this month's issue of Florida Trend.


Florida Business News

Florida Trend Video Pick

Test driving the Bugatti Chiron
Test driving the Bugatti Chiron

What's it like to drive a $3 million car in the streets of Miami? 

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

With the end of the year approaching, do you still have a lot of unused vacation time to take?

  • Yes, on purpose
  • Yes, but unintentional (I hope I don't lose vacation time)
  • Not a lot, but some
  • No
  • N/A (retired or not working)

See Results

Ballot Box